Skip to main content
Family Medicine
ALL Specialities
ALL Specialities
/
Family Medicine
CME
COVID-19 Updates
The Journal of Family Practice
Current Issue
Past Issues
Author Guidelines
Specialties
Addiction Medicine
Cardiology
Dermatology
Diabetes
Endocrinology
Gastroenterology
Geriatrics
Hematology
Hepatology
Hospice & Palliative Medicine
Immunology
Infectious Diseases
Men's Health
Mental Health
Nephrology
Neurology
Oncology
Pain
Pediatrics
Pulmonology
Rheumatology
Sleep Medicine
Transgender Health
Women's Health
For Residents
Residents' Rapid Review
Multimedia
Audio
All Podcasts
Practice Alert Podcast
Video
3-in-3
Watch & Learn
Conference Coverage
Biogen’s aducanumab stumbles on cognitive endpoints at 6 mg/kg dose
Publish date:
July 23, 2015
FROM AAIC 2015
References
msullivan@frontlinemedcom.com
On Twitter
@Alz_Gal
Pages
« first
1
2
Recommended Reading
VIDEO: Stroop app predicts hepatic encephalopathy
MDedge Family Medicine
Prevalence of amyloid pathology differs across dementia type and age
MDedge Family Medicine
Hormone therapy helps mood, but not cognition, in younger menopausal women
MDedge Family Medicine
Cognitive impairment signals subclinical vascular disease
MDedge Family Medicine
Mixed pathologies are very common in black Alzheimer’s patients
MDedge Family Medicine
AAIC: Sedentary early adulthood may mean worse cognitive functioning later
MDedge Family Medicine
VIDEO: Dementia risk doubled in type 1 diabetes patients
MDedge Family Medicine
VIDEO: Investigating the role of plasmalogens in Alzheimer’s disease
MDedge Family Medicine
Estrogen therapy linked to brain atrophy in women with diabetes
MDedge Family Medicine
VIDEO: Postoperative cognitive decline hits women hardest
MDedge Family Medicine
Geriatrics
Neurology
All Specialties